Advertisement

Two Implantable Devices for Cardiac Rhythm Management

Published:October 28, 2022DOI:https://doi.org/10.1053/j.jvca.2022.10.027
      A 53-year-old, 104- kg, 165- cm woman with nonischemic cardiomyopathy with a reduced ejection fraction of 30%-to-35% secondary to cardiac sarcoidosis was admitted for decompensated heart failure. She previously had a single-chamber implantable cardioverter-defibrillator (ICD) placed via a left pectoral approach for the primary prevention of sudden cardiac death. Considering that the patient was on maximally tolerable guideline-directed medical therapy for heart failure with reduced ejection fraction, and was not a candidate for cardiac resynchronization therapy, the decision was made to augment her systolic function with a cardiac rhythm management device. After an uneventful implantation of her new device, a chest radiograph (Fig 1) and electrocardiogram showing changes (Fig 2, Fig 3) were obtained. What is the diagnosis?
      Fig 1
      Fig 1Chest x-ray with evidence of implanted cardioverter-defibrillator (red circle) and OPTIMIZER device (blue circle) and 2 right ventricular septal leads (yellow arrows).
      Fig 2
      Fig 2Electrocardiogram with cardiac contractility modulation therapy OFF.
      Fig 3
      Fig 3Electrocardiogram with cardiac contractility modulation therapy ON.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Cardiothoracic and Vascular Anesthesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lyon AR
        • Samara MA
        • Feldman DS.
        Cardiac contractility modulation therapy in advanced systolic heart failure.
        Nat Rev Cardiol. 2013; 10: 584-598
      1. Impulse Dynamics. OPTIMIZER Smart Mini Implantable Pulse Generator instructions for use. Available at: http://www.impulse-dynamics.com/us-technical-documents/. Accessed October 5, 2022.

        • Wutzler A
        • De Asmundis C
        • Matsuda H
        • et al.
        Effects of propofol on ventricular repolarization and incidence of malignant arrhythmias in adults.
        J Electrocardiol. 2018; 51: 170-174
        • Oji M
        • Terao Y
        • Toyoda T
        • et al.
        Differential effects of propofol and sevoflurane on QT interval during anesthetic induction.
        J Clin Monit Comput. 2013; 27: 243-248